LATANOPROST for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where LATANOPROST was used for Psoriasis.
Most Reported Side Effects for LATANOPROST
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Treatment failure | 5,781 | 37.6% | 0 | 0 |
| Drug ineffective | 1,338 | 8.7% | 8 | 61 |
| Eye irritation | 1,165 | 7.6% | 2 | 32 |
| Eye pain | 668 | 4.4% | 0 | 35 |
| Hypersensitivity | 668 | 4.4% | 0 | 14 |
| Ocular hyperaemia | 587 | 3.8% | 1 | 16 |
| Intraocular pressure increased | 579 | 3.8% | 0 | 40 |
| Vision blurred | 564 | 3.7% | 1 | 29 |
| Cataract | 546 | 3.6% | 3 | 55 |
| Visual impairment | 382 | 2.5% | 1 | 34 |
| Drug hypersensitivity | 377 | 2.5% | 1 | 26 |
| Glaucoma | 349 | 2.3% | 3 | 46 |
| Eye pruritus | 345 | 2.3% | 1 | 12 |
| Product quality issue | 332 | 2.2% | 0 | 7 |
| Headache | 306 | 2.0% | 1 | 14 |
Other Indications for LATANOPROST
Product used for unknown indication (8,359)
Glaucoma (3,296)
Intraocular pressure increased (586)
Open angle glaucoma (289)
Ocular hypertension (184)
Intraocular pressure test abnormal (115)
Intraocular pressure test (94)
Cataract (54)
Eye disorder (50)
Macular degeneration (35)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)